"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".
There is an interest in understanding the association between early calcineurin inhibitors (CNI) exposure post-Liver Transplantation (LT) and long-term outcomes. We aimed to analyze this association exploring median CNI levels and intrapatient-variability (IPV) in a multicenter, retrospective cohort. Tac and CsA levels obtained during the first 15 days post LT were collected. High-immunosuppression (IS) was considered as a median Tac, CsA C0 or C2 higher than 10 ng/ml, 250 ng/ml or 1200 ng/ml, respectively or a peak of Tac > 20 ng/ml. Optimal-IS was defined as a median of Tac, CsA C0 or C2 levels between 7-10 ng/ml, 150-250 ng/ml or 800-1200 ng/ml. Low-IS was defined as below the thresholds of optimal-IS. IPV was estimated during the first 15 days post-LT. The study included 432 patients with a median follow up of 8.65 years. Immunosuppression regimen was based on either Tac or CsA in 243 (56.3%) and 189 (43.8%), respectively. There were no differences in terms of graft loss among low versus optimal and high-IS groups (p= 0.812 and p=0.451) nor in high vs low IPV (p=0.835). Only viral hepatitis and arterial hypertension were independently associated with higher graft loss (HR 1.729, p= 0.029 and HR 1.570, p=0.021). In our series, and in contrast to what has previously been reported, no association was found between very-early postoperative over-IS or high-IPV and long-term outcome measures following LT. Strategies aimed at reducing these long-term events should likely focus on other factors or on a different IS time window.